One Brave Idea, founded in 2016, is a medical service provider specializing in cardiology, data science, and engineering solutions. The organization’s core mission is to eradicate coronary heart disease by identifying the earliest departure from wellness to disease. Their vision is to bridge the gap between academia, industry, and medicine through innovative research and multidisciplinary collaboration. One Brave Idea focuses on deep phenotyping to characterize new phenotypes for coronary heart disease, aiming to revolutionize early detection and prevention strategies.

Notable affiliated individuals include leading scientists and researchers from diverse fields such as cardiology, data science, and engineering. The initiative has received significant funding from prominent investors including the American Heart Association, Verily (formerly Google Life Sciences), and AstraZeneca. Key achievements include pioneering new approaches to understanding coronary heart disease and fostering a collaborative environment that integrates fresh thoughts, tools, and techniques. Overall, One Brave Idea has made a substantial impact by advancing the scientific understanding of heart disease and promoting early intervention methods.